Literature DB >> 3949931

Determination of debrisoquine and its 4-hydroxy metabolite in urine by high-performance liquid chromatography.

P M Harrison, A M Tonkin, S T Dixon, A J McLean.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3949931     DOI： 10.1016/s0378-4347(00)83273-9

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  6 in total

1.  Correlations among the metabolic ratios of three test probes (metoprolol, debrisoquine and sparteine) for genetically determined oxidation polymorphism in a Japanese population.

Authors:  Y Horai; J Taga; T Ishizaki; K Ishikawa
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

2.  The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates.

Authors:  H Sakai; S Kobayashi; K Hamada; S Iida; H Akita; E Tanaka; E Uchida; H Yasuhara
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

3.  Flecainide: evidence of non-linear kinetics.

Authors:  G Boriani; E Strocchi; A Capucci; R Callivà; L Frabetti; E Ambrosioni; B Magnani
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Minimal effective concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapy.

Authors:  A Capucci; G Boriani; B Marchesini; E Strocchi; L Tomasi; M Balducelli; L Frabetti; E Ambrosioni; B Magnani
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

5.  Debrisoquine hydroxylation in a Polish population.

Authors:  P K Kunicki; D Sitkiewicz; A Pawlik; V Bielicka-Sulzyc; E Borowiecka; B Gawrońska-Szklarz; R Sterna; H Matsumoto; M Radziwoń-Zaleska
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

6.  Metabolism of debrisoquine and susceptibility to breast cancer.

Authors:  J Huober; B Bertram; E Petru; M Kaufmann; D Schmähl
Journal:  Breast Cancer Res Treat       Date:  1991-03       Impact factor: 4.872
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.